Alnylam Pharmaceuticals (ALNY) EBT Growth (3y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 32.79% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 47.54% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -49.71% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 12.01% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 20.92% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1.05% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 48.67% |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 48.67% |
| Dec 31, 2025 | 34.20% |
| Sep 30, 2025 | 39.10% |
| Jun 30, 2025 | 49.51% |
| Mar 31, 2025 | 78.53% |
| Dec 31, 2024 | 9.34% |
| Sep 30, 2024 | 18.97% |
| Jun 30, 2024 | 61.01% |
| Mar 31, 2024 | 31.67% |
| Dec 31, 2023 | 17.32% |
| Sep 30, 2023 | 37.46% |
| Jun 30, 2023 | -15.51% |
| Mar 31, 2023 | 1.73% |
| Dec 31, 2022 | 9.20% |
| Sep 30, 2022 | -24.78% |
| Jun 30, 2022 | -7.92% |
| Mar 31, 2022 | -9.72% |
| Dec 31, 2021 | -7.24% |
| Sep 30, 2021 | 5.86% |
| Jun 30, 2021 | -4.83% |
| Mar 31, 2021 | -12.15% |
| Dec 31, 2020 | -19.65% |
| Sep 30, 2020 | -27.11% |
| Jun 30, 2020 | -14.53% |
| Mar 31, 2020 | -19.19% |
| Dec 31, 2019 | -34.67% |
| Sep 30, 2019 | -25.99% |
| Jun 30, 2019 | -34.34% |
| Mar 31, 2019 | -20.73% |
| Dec 31, 2018 | -32.51% |
| Sep 30, 2018 | -47.18% |
| Jun 30, 2018 | -31.83% |
| Mar 31, 2018 | -40.25% |
| Dec 31, 2017 | -48.44% |
| Sep 30, 2017 | -40.93% |
| Jun 30, 2017 | -38.69% |
| Mar 31, 2017 | 26.37% |
| Dec 31, 2016 | -56.86% |
| Sep 30, 2016 | -48.42% |
| Jun 30, 2016 | -62.37% |
| Mar 31, 2016 | -120.73% |
| Dec 31, 2015 | -59.78% |
| Sep 30, 2015 | -57.91% |
| Jun 30, 2015 | -76.60% |
| Mar 31, 2015 | -65.15% |
| Dec 31, 2014 | -44.34% |
| Sep 30, 2014 | -49.15% |
| Jun 30, 2014 | -47.53% |
| Mar 31, 2014 | -154.62% |
| Dec 31, 2013 | -65.23% |
| Sep 30, 2013 | -50.73% |
| Jun 30, 2013 | -12.31% |
| Mar 31, 2013 | 8.02% |
| Dec 31, 2012 | 94.01% |
| Sep 30, 2012 | -25.95% |
| Jun 30, 2012 | 15.92% |